Physician profile
Joseph A Larsen
NPI 1629193941
$89,717.98
in general payments reported to CMS, 2019-2025
37 companies · $6,336 in 2025
The $6,336 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $8,278 · 2020: $6,318 · 2021: $9,577 · 2022: $19K · 2023: $23K · 2024: $17K · 2025: $6,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Food and Beverage: $12K · Travel and Lodging: $6,335 · Royalty Or License: $603 · Entertainment: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,450.00 |
| Food and Beverage | $11,828.92 |
| Travel and Lodging | $6,335.26 |
| Royalty Or License | $602.71 |
| Entertainment | $160.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $53,604.03 | 2020-2025 | |
| Royal Biologics, INC. | $18,506.30 | 2019-2022 | |
| Gramercy Extremity Orthopedics LLC | $5,637.49 | 2022-2025 | |
| Next Science LLC | $3,107.80 | 2023-2025 | Xperience, Blastx, Surgx |
| Polynovo North America LLC | $2,185.12 | 2024-2025 | Novosorb Btm |
| Acera Surgical, INC. | $1,081.90 | 2022-2025 | Restrata Wound Matrix |
| Medline Industries LP | $641.47 | 2019-2024 | |
| Medshape, INC. | $604.68 | 2023-2025 | Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm, Dynanail Helix, Washer, 15 Mm, Dynanail |
| Organogenesis INC. | $452.70 | 2019-2021 | |
| Djo, LLC | $405.80 | 2020-2023 | Cmf |
| Stryker Corporation | $374.71 | 2021-2025 | Citrefix, Flexband |
| Treace Medical Concepts, INC. | $352.80 | 2024-2025 | |
| Encore Medical, LP | $342.91 | 2022 | |
| Orthofix Medical, INC. | $324.86 | 2019-2025 | Physio-Stim |
| Trilliant Surgical LLC. | $310.27 | 2022-2025 | Arsenal Sinus Support Plate |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $268.86 | 2020-2022 | |
| Novastep INC. | $184.03 | 2021 | |
| Integra Lifesciences Corporation | $181.10 | 2020 | |
| Boston Scientific Corporation | $141.20 | 2022 | |
| Baxter Healthcare | $137.21 | 2019-2024 | Actifuse |
| Smith+Nephew, INC. | $130.79 | 2020-2024 | Grafix Pl, Pico 7 |
| Abbvie INC. | $128.42 | 2021-2022 | |
| Stability Biologics, LLC | $126.86 | 2022 | |
| Lifenet Health | $96.34 | 2025 | Theragenesis Wound Matrix |
| Tactile Systems Technology INC | $92.10 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Paragon 28, INC. | $48.44 | 2023 | Mtp |
| Zimmer Biomet Holdings, INC. | $42.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $39.61 | 2022-2023 | Seglentis |
| Sebela Pharmaceuticals INC. | $30.06 | 2020 | |
| Ibsa Pharma INC. | $22.00 | 2023 | Tirosint, Licart |
| Polaris Technology Solutions LLC | $21.73 | 2025 | |
| Merck Sharp & Dohme LLC | $18.83 | 2019 | |
| Wright Medical Technology, INC. | $18.35 | 2019 | |
| Bioventus LLC | $15.85 | 2022 | |
| Allergan, INC. | $15.65 | 2020 | |
| Reprise Biomedical, INC. | $12.57 | 2021 | |
| Alfasigma USA, INC. | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Larsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.